glp-1 vs glp Understanding receptor agonists and their impact on drug discovery GLP-1 receptor agonists | How

However, clinically it is apparent that many patients do not require the maximum recommended dose to achieve weight loss

More specifically, an in vivo study, based on chronic 40-day peripheral administration of lixisenatide to high-fat fed mice with established obesity, insulin resistance and impaired cognition, found that lixisenatide significantly upregulated expression of the neurotrophic tyrosine kinase receptor type 2 ( NTRK2 ) gene and of the mammalian target of rapamycin ( mTOR ) gene in the hippocampus, which are involved in regulating synaptic plasticity [100]

International Journal of Molecular Sciences 24, 8323

But it's still day 1, and we've got a long way to go to achieve our Mission of changing 1B lives by reversing diabetes and solving obesity through nutrition